For topical dermatologic use only and not for ophthalmic or intravaginal use.
OXISTAT® (oxiconazole nitrate) Lotion is contraindicated in individuals who have shown hypersensitivity to any of its components. If a reaction suggesting sensitivity or chemical irritation should occur with the use of OXISTAT® Lotion, treatment should be discontinued and appropriate therapy instituted. If signs of epidermal irritation should occur, the drug should be discontinued.
In a clinical trial with OXISTAT® Lotion (N=269), the most common adverse events were burning and stinging (0.7% each) and pruritus, scaling, tingling, pain and dyshidrotic eczema (0.4% each).
Please see Full Prescribing Information for OXISTAT® Lotion.
You are encouraged to report negative side effects of prescription drugs to the FDA. Please visit www.fda.gov/medwatch or call 1-800-FDA-1088.
OXISTAT® Lotion is indicated for the topical treatment of the following dermal infections: tinea pedis, tinea cruris, and tinea corporis due to Trichophyton rubrum, Trichophyton mentagrophytes, or Epidermophyton floccosum.
The information on this site is intended for U.S. residents only.
OXISTAT® is a registered trademark of Fougera Pharmaceuticals, Inc.
© 2021 ANI Pharmaceuticals, Inc. All rights reserved.
Site Map
| Terms of Use |
Privacy Policy |
ANI Pharmaceuticals, Inc
The information on this site is intended for U.S. residents only.
10470 Rev 06/21
ANI Pharmaceuticals, Inc. is not responsible for the privacy policy, the content, or the accuracy of any websites accessed through a link on the OXISTAT.com site. A link to other websites does not constitute an endorsement of ANI Pharmaceuticals or the linked site, its products, or services.
The browser window or tab for OXISTAT.com will remain open. To return to OXISTAT.com at any time, close this tab or window.
ANI Pharmaceuticals, Inc. is not responsible for the privacy policy, the content, or the accuracy of any websites accessed through a link on the OXISTAT.com site. A link to other websites does not constitute an endorsement of ANI Pharmaceuticals or the linked site, its products, or services.
The browser window or tab for OXISTAT.com will remain open. To return to OXISTAT.com at any time, close this tab or window.
ANI Pharmaceuticals, Inc. is not responsible for the privacy policy, the content, or the accuracy of any websites accessed through a link on the OXISTAT.com site. A link to other websites does not constitute an endorsement of ANI Pharmaceuticals or the linked site, its products, or services.
The browser window or tab for OXISTAT.com will remain open. To return to OXISTAT.com at any time, close this tab or window.
ANI Pharmaceuticals, Inc. is not responsible for the privacy policy, the content, or the accuracy of any websites accessed through a link on the OXISTAT.com site. A link to other websites does not constitute an endorsement of ANI Pharmaceuticals or the linked site, its products, or services.
The browser window or tab for OXISTAT.com will remain open. To return to OXISTAT.com at any time, close this tab or window.
ANI Pharmaceuticals, Inc. is not responsible for the privacy policy, the content, or the accuracy of any websites accessed through a link on the OXISTAT.com site. A link to other websites does not constitute an endorsement of ANI Pharmaceuticals or the linked site, its products, or services.
The browser window or tab for OXISTAT.com will remain open. To return to OXISTAT.com at any time, close this tab or window.
ANI Pharmaceuticals, Inc. is not responsible for the privacy policy, the content, or the accuracy of any websites accessed through a link on the OXISTAT.com site. A link to other websites does not constitute an endorsement of ANI Pharmaceuticals or the linked site, its products, or services.
The browser window or tab for OXISTAT.com will remain open. To return to OXISTAT.com at any time, close this tab or window.
This infection can occur anywhere on the foot, but it often appears between the toes or on the bottoms or sides of the feet. Symptoms include: